1095 related articles for article (PubMed ID: 33717193)
1. Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies.
Ricke DO
Front Immunol; 2021; 12():640093. PubMed ID: 33717193
[TBL] [Abstract][Full Text] [Related]
2. Multiple Routes of Antibody-Dependent Enhancement of SARS-CoV-2 Infection.
Okuya K; Hattori T; Saito T; Takadate Y; Sasaki M; Furuyama W; Marzi A; Ohiro Y; Konno S; Hattori T; Takada A
Microbiol Spectr; 2022 Apr; 10(2):e0155321. PubMed ID: 35319248
[TBL] [Abstract][Full Text] [Related]
3. Antibody-dependent enhancement (ADE) of SARS-CoV-2 in patients exposed to MERS-CoV and SARS-CoV-2 antigens.
Thomas S; Smatti MK; Alsulaiti H; Zedan HT; Eid AH; Hssain AA; Abu Raddad LJ; Gentilcore G; Ouhtit A; Althani AA; Nasrallah GK; Grivel JC; Yassine HM
J Med Virol; 2024 May; 96(5):e29628. PubMed ID: 38682568
[TBL] [Abstract][Full Text] [Related]
4. Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages.
Maemura T; Kuroda M; Armbrust T; Yamayoshi S; Halfmann PJ; Kawaoka Y
mBio; 2021 Oct; 12(5):e0198721. PubMed ID: 34579572
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection.
Conway SR; Lazarski CA; Field NE; Jensen-Wachspress M; Lang H; Kankate V; Durkee-Shock J; Kinoshita H; Suslovic W; Webber K; Smith K; Cohen JI; Burbelo PD; Zhang A; Teach SJ; Ibeh T; Delaney M; DeBiasi RL; Keller MD; Bollard CM
Front Immunol; 2021; 12():793197. PubMed ID: 35116027
[TBL] [Abstract][Full Text] [Related]
6. A perspective on potential antibody-dependent enhancement of SARS-CoV-2.
Arvin AM; Fink K; Schmid MA; Cathcart A; Spreafico R; Havenar-Daughton C; Lanzavecchia A; Corti D; Virgin HW
Nature; 2020 Aug; 584(7821):353-363. PubMed ID: 32659783
[TBL] [Abstract][Full Text] [Related]
7. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
8. Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models.
Li D; Luan N; Li J; Zhao H; Zhang Y; Long R; Jiang G; Fan S; Xu X; Cao H; Wang Y; Liao Y; Wang L; Liu L; Liu C; Li Q
Emerg Microbes Infect; 2021 Dec; 10(1):2194-2198. PubMed ID: 34736354
[TBL] [Abstract][Full Text] [Related]
9. No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection.
García-Nicolás O; V'kovski P; Zettl F; Zimmer G; Thiel V; Summerfield A
Front Cell Infect Microbiol; 2021; 11():644574. PubMed ID: 33912475
[TBL] [Abstract][Full Text] [Related]
10. Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19).
Anderson EM; Diorio C; Goodwin EC; McNerney KO; Weirick ME; Gouma S; Bolton MJ; Arevalo CP; Chase J; Hicks P; Manzoni TB; Baxter AE; Andrea KP; Burudpakdee C; Lee JH; Vella LA; Henrickson SE; Harris RM; Wherry EJ; Bates P; Bassiri H; Behrens EM; Teachey DT; Hensley SE
J Pediatric Infect Dis Soc; 2021 May; 10(5):669-673. PubMed ID: 33263756
[TBL] [Abstract][Full Text] [Related]
11. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
Wan Y; Shang J; Sun S; Tai W; Chen J; Geng Q; He L; Chen Y; Wu J; Shi Z; Zhou Y; Du L; Li F
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826992
[TBL] [Abstract][Full Text] [Related]
13. The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemic.
Rothan HA; Byrareddy SN
Pediatr Allergy Immunol; 2021 Jan; 32(1):17-22. PubMed ID: 32897642
[TBL] [Abstract][Full Text] [Related]
14. Multisystem inflammatory syndrome in neonates (MIS-N) associated with SARS-CoV2 infection: a case series.
More K; Aiyer S; Goti A; Parikh M; Sheikh S; Patel G; Kallem V; Soni R; Kumar P
Eur J Pediatr; 2022 May; 181(5):1883-1898. PubMed ID: 35031848
[TBL] [Abstract][Full Text] [Related]
15. A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in children.
Sananez I; Raiden SC; Algieri SC; Uranga M; Grisolía NA; Filippo D; De Carli N; Lalla SD; Cairoli H; Chiolo MJ; Meregalli CN; Cohen E; Mosquera G; Marcó Del Pont M; Giménez LI; Gregorio G; Sarli M; Alcalde AL; Davenport C; Bruera MJ; Simaz N; Pérez MF; Nivela V; Bayle C; Alvarez L; Revetria M; Tuccillo P; Agosta MT; Pérez H; Nova SV; Suárez P; Takata EM; García M; Lattner J; Rolón MJ; Coll P; Salvatori M; Piccardo C; Russo C; Varese A; Seery V; Holgado MP; Polo ML; Ceballos A; Nuñez M; Penedo JMG; Ferrero F; Geffner J; Arruvito L
EBioMedicine; 2021 Oct; 72():103615. PubMed ID: 34649078
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19.
Ravichandran S; Tang J; Grubbs G; Lee Y; Pourhashemi S; Hussaini L; Lapp SA; Jerris RC; Singh V; Chahroudi A; Anderson EJ; Rostad CA; Khurana S
Nat Immunol; 2021 Nov; 22(11):1452-1464. PubMed ID: 34611361
[TBL] [Abstract][Full Text] [Related]
17. Age-Related Differences in Immunological Responses to SARS-CoV-2.
Wong LSY; Loo EXL; Kang AYH; Lau HX; Tambyah PA; Tham EH
J Allergy Clin Immunol Pract; 2020; 8(10):3251-3258. PubMed ID: 32861856
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome.
Huang JJ; Gaines SB; Amezcua ML; Lubell TR; Dayan PS; Dale M; Boneparth AD; Hicar MD; Winchester R; Gorelik M
J Allergy Clin Immunol; 2022 Mar; 149(3):912-922. PubMed ID: 34688775
[TBL] [Abstract][Full Text] [Related]
19. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
Front Immunol; 2021; 12():632890. PubMed ID: 33732254
[TBL] [Abstract][Full Text] [Related]
20. Antibody-dependent enhancement of coronavirus.
Wen J; Cheng Y; Ling R; Dai Y; Huang B; Huang W; Zhang S; Jiang Y
Int J Infect Dis; 2020 Nov; 100():483-489. PubMed ID: 32920233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
